Ocuphire Pharma (OCUP) Competitor Comparison
We are evaluating the key criteria listed to compare Ocuphire Pharma (OCUP) against its competitors in the Biotechnology industry.
Market Capitalization
284 / 368Gross Profits
0 / 278Total Revenue
114 / 300EBITDA
25 / 337Free Cashflow
29 / 352Quick Ratio
51 / 357Earnings per Share
85 / 359Dividend yield
0 / 6Total Cash
270 / 358Performance 3 years
218 / 368Performance 5 years
261 / 368Performance 10 years
345 / 368Linearity 3 years
115 / 368Linearity 5 years
179 / 368Linearity 10 years
275 / 368Total Rank
11 / 368Dividend Rank
224 / 368Valuation Rank
20 / 368Piotroski Rank
80 / 368Muliplier Rank
64 / 368Total Cash - OCUP ranking 270 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.